Akichika Ozeki

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Psychometric Properties

Clinical Evaluation

Top Venues

Neurology and therapy

Journal of pain research

This page only lists publications with an associated author ORCID identifier.

Publications

Takao Takeshima, Hikaru Doi, Satomi Ooba, Yuka Tanji, Akichika Ozeki, Mika Komori
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study. Neurology and therapy 13 (3) (2024)
Takao Takeshima, Hikaru Doi, Satomi Ooba, Yuka Tanji, Akichika Ozeki, Mika Komori
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study. Neurology and therapy 13 (3) (2024)
Takao Takeshima, Hikaru Doi, Satomi Ooba, Yuka Tanji, Akichika Ozeki, Mika Komori
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study. Neurology and therapy 13 (3) (2024)
Takao Takeshima, Hikaru Doi, Satomi Ooba, Yuka Tanji, Akichika Ozeki, Mika Komori
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study. Neurology and therapy (2024)
Takao Takeshima, Hikaru Doi, Satomi Ooba, Yuka Tanji, Akichika Ozeki, Mika Komori
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study. Neurology and therapy 13 (3) (2024)
Shigekazu Kitamura, Noboru Imai, Yuka Tanji, Akichika Ozeki, Mika Komori
Lasmiditan in Japanese Patients with Common Migraine Comorbidities or Concomitant Medications: A Post Hoc Safety and Efficacy Analysis from the MONONOFU Study. Journal of pain research 16 (2023)
Hisaka Igarashi, Mamoru Shibata, Akichika Ozeki, Taka Matsumura
Galcanezumab Effects on Migraine Severity and Symptoms in Japanese Patients with Episodic Migraine: Secondary Analysis of a Phase 2 Randomized Trial. Neurology and therapy (2022)
Yasuhiko Matsumori, Mika Komori, Yuka Tanji, Akichika Ozeki, Fumihiko Sakai
Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial. Neurology and therapy 11 (4) (2022)
Hisaka Igarashi, Mamoru Shibata, Akichika Ozeki, Kathleen Ann Day, Taka Matsumura
Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine. Journal of pain research 14 (2021)
Mamoru Shibata, Tomomi Nakamura, Akichika Ozeki, Kaname Ueda, Russell M Nichols
Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study. Journal of pain research 13 (2020)